Hello fellow wrestlers ... this is my first post ;"first time caller, long-time listener." By nature I have a tendency to hang out in the background and avoid the spotlight (well, unless I've had a few tee many martoonies). I've been undergoing treatment for advanced triple negative breast cancer (mets to lungs) since January and have been struggling, to say the least, with the emotional and physical tolls of this damned disease and the effects of the treatment (currently on Taxol, stopped Avastin a month ago).
I've been lurking around for quite a while being inspired by so many of you and also saddened by the very recent losses of some very dear members right along with you. I have allowed myself to wallow in the victimization of the statistics and it's been difficult for me to contribute to this forum because I just haven't had much positive to offer. Lately, however, I've been coming to terms with everything a little bit (two steps forward, one step back type of thing) and decided I wanted to jump in with all of you already.
I hate that I have to be here but I must say that I am honored to be part of a group of such lovely, strong, intelligent women (I know, there's a couple of guys, too, and you are also awesome!). So, with that somewhat long intro I am brought to my actual reason for posting, an article that caught my eye while waiting for chemo today. My apologies to the organization if I am supposed to have some special permission to reprint this, but, I thought it was of interest and really wanted to share it ...
-------------------------------------------------
From Komen Connection, Spring 2009, Volume V, Issue 1
Milwaukee Chapter, Janet Zylstra, Komen Milwaukee Affiliate President
Triple Negative Breast Cancer
When Nancy Block-Zenna was diagnosed in 2005 with the rare and aggressive form of breast cancer known as triple negative breast cancer, two of her friends created the Triple Negative Breast Cancer Foundation (TNBCF) with just $9,000 to raise awareness and funds for the disease. TNBCF is now a major advocacy organization for women with this form of the disease.
Many of us at Susan G. Komen for the Cure ® have admired TNBCF’s work, and are delighted to formalize our relationship recently with a partnership that is the harbinger of even more promising collaborations to come.
Triple negative breast cancer accounts for about 15% of all cases in the U.S., which means that approximately 25,000 women are diagnosed with the disease every year. It disproportionately affects younger women and women of color and has a higher mortality rate than other breast cancers.
Today, we know breast cancer isn’t just one disease with one type of treatment. The disease takes many forms, and is generally described based on the presence or “expression” of three receptors known to fuel most breast cancers: estrogen, progesterone, and human epidermal growth factor 2 (HER2).
Triple negative breast cancer does not express HER2, or the estrogen or progesterone receptors. That’s why it’s called “triple negative.” At some point in the near future, we hope to describe triple negative breast cancers based on what they are, not based on what they are not.
Many treatments for breast cancer available today use the HER2, estrogen receptor or progesterone receptor as a target. But because those receptors just aren’t present or active, hormone treatments and HER2-targeted therapies won’t work for TNBC patients.
Currently, various types of chemotherapy, and perhaps the anti-angiogenic drug bevacizumab (Avastin) are the only effective systemic therapies for TNBC. Chemotherpay is usually given after a woman has initial breast surgery, but it may be given prior to surgery as well.
And while chemotherapy actually works better in TNBC cases than in other form of breast cancer, it doesn’t work for everyone and doesn’t work well enough for some patients. Many women also receive radiation in addition to chemotherapy.
Some people have though that TNBS is an automatic death sentence. However, most women with TNBC doe quite well, even years after beginning treatment. The problem, however, is that a substantial minority do not do as well.
Komen began funding Promise Grants in 2008 to accelerate the pace of research with the hope of delivering cures more rapidly. The first grants were targeted to inflammatory breast cancer (another highly challenging form of breast cancer), to understanding how obesity may affect the progression of breast cancer, and to development of new treatments for estrogen receptor-negative breast cancer.
Komen is making it clear to researchers around the world that we want to do more about TNBC. Researchers are asked to submit grants that specifically focus on the triple negative breast cancer issue. Such a signal is bound to increase research in this area.
The partnership between Komen and the Triple Negative Breast Cancer Foundation is emblematic of what needs to be done more often as we move toward the goal of a world free of breast cancer. Advocacy groups wherever – and whenever – need to combine thir financial as well as intellectual resources to produce better results faster. For more information about Susan G. Komen for the Cure, breast health or breast cancer, please visit www.komen.org or call 1-877 GO KOMEN. And, to learn more about the Triple Negative Breast Cancer Foundation, visit www.tnbcfoundation.org.
----------------------------------------
I know many of you ladies are familiar with TNBCF but I wasn't sure if you were aware of the Promise Grants from the Komen organization for Triple Negative. This was a pleasant surprise to me. I didn't have time today, but I do want to contact them and find out if donations can be specifically allocated to the effort.
I also posted this article on my caringbridge and facebook pages in the hopes of getting the word out through my loved ones.
Well, that's my little contribution for now. Wonderful to meet you all. Thanks for the endless laughs, encouragement and knowledge that is shared. I look forward to being a part of this endeavor.
Have a lovely evening!
Bev~




Add to the discussion